Survey of Satisfaction on Traditional Chinese Medicine Jing-Guan-Fang (JGF) for COVID-19 Prevention

Department of Chinese Medicine, Branch of Linsen, Chinese Medicine, and Kunming, Taipei City Hospital, Taipei, Taiwan Institute of Traditional Medicine, National Yang-Ming University, Taipei, Taiwan.

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04388644

Enrollment

300

Registered

2020-05-14

Start date

2020-02-20

Completion date

2020-05-30

Last updated

2020-05-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Corona Virus Infection

Keywords

natural herbal medicine, Chinese medicine

Brief summary

the retrospective observation study, the first line to care CAVID-19

Detailed description

The satisfaction of using nature herbal medicine for frontline medical staffs to prevent COVID-19: a retrospective clinical study. The medical frontline staffs have the high risk to be infected during working. The stress and load were acuminated, especially when they got the similar symptoms as COVID-19. NHM has been used to early prevention for thousands of years9-12. It was well accept to take NHM for early prevention in many Asia-Pacific countries. Although many NHM remedies of COVID-19 treatment or prevention were reported, but the related study were lacking. To understand the pressure and the satisfaction of frontline medical staffs after taking JGF for early prevention we conducted this retrospective clinical study to explore the relationship in different groups.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

20 Years to 65 Years

Healthy volunteers

Yes

Inclusion criteria

* The person first-line medical staff in hospital * the inspection personnel in airport * self-quarantine at home. * self-quarantine at office.

Exclusion criteria

* no willing to participate * allergy to herbal medicine * severe illness evaluated by physician

Design outcomes

Primary

Measure	Time frame	Description
the number confirmed COVID-19 cases	8 weeks	The isolated person and first-line care person who taking JGF
The person with COVID-19 like symptoms	8 weeks	The isolated person and first-line care person who taking JGF

Secondary

Measure	Time frame	Description
The improving rate of COVID-19 like symptoms	8 weeks	The isolated person and first-line care person who taking JGF
The satisfaction% to taking JGF	8 weeks	The isolated person and first-line care person who taking JGF

Countries

Taiwan

Contacts

Primary ContactChung Hua Hsu, PhD

dap63@tpech.gov.tw886-2-23887088

Outcome results